Allena Pharmaceuticals, Inc.
ALNADelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001624658
Allena Pharmaceuticals, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Feb 2, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.71M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Allena Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 17.0M | 8.05M | −8.96M (−52.7%) |
| Value | $10.1M | $1.86M | −$8.21M (−81.5%) |
New holders (4)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| RFG Advisory, LLC | 11,000 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 10,645 | $2.00K | 0.00% |
| Citigroup Inc | 2,600 | $1.00K | 0.00% |
| Prospera Financial Services Inc | 5,550 | $1.00K | 0.00% |
Sold out (6)
Institutions that held Allena Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| AIGH Capital Management LLC | 4,000,000 | $2.37M |
| Worth Venture Partners, LLC | 980,200 | $581.0K |
| PFM Health Sciences, LP | 284,285 | $168.0K |
| Natixis | 50,000 | $30.0K |
| The PNC Financial Services Group, Inc. | 10,000 | $6.00K |
| TAP Consulting, LLC | 30 | $0 |